Rameen Beroukhim
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Genomic variations and chromosomal abnormalities
Papers in
- Genetics 44
- Glioma Diagnosis and Treatment 44
- Genomic variations and chromosomal abnormalities 13
-
- Cancer Genomics and Diagnostics 42
- Co-authors
- Matthew MeyersonGad GetzSteven E. SchumacherCraig H. MermelBarbara HillWilliam R. SellersTodd R. GolubMark A. Rubin
- Journals
- Neuro-Oncology (12 papers)Journal of Clinical Oncology (12 papers)Cancer Research (10 papers)Journal of Neuro-Oncology (8 papers)Nature Genetics (8 papers)
- Partner nations
- United StatesGermanyNorway
In The Last Decade
Rameen Beroukhim
149 papers receiving 16.7k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 6.1k
- Genetics 1.8k
- Oncology 4.1k
- Molecular Biology 10.0k
- Pulmonary and Respiratory Medicine 3.2k
Countries citing papers authored by Rameen Beroukhim
This map shows the geographic impact of Rameen Beroukhim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rameen Beroukhim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rameen Beroukhim more than expected).
Fields of papers citing papers by Rameen Beroukhim
This network shows the impact of papers produced by Rameen Beroukhim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rameen Beroukhim. The network helps show where Rameen Beroukhim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rameen Beroukhim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2021 | 1 | |
| 3 | 2020 | 11 | |
| 4 | 2020 | 67 | |
| 5 | 2020 | 13 | |
| 6 | 2019 | 4 | |
| 7 | Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate Hit paper breakdown → | 2019 | 280 |
| 8 | 2018 | 21 | |
| 9 | 2018 | 181 | |
| 10 | 2016 | 88 | |
| 11 | 2015 | 49 | |
| 12 | 2015 | 63 | |
| 13 | Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene Hit paper breakdown → | 2011 | 313 |
| 14 | 2009 | 334 | |
| 15 | Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney Hit paper breakdown → | 2009 | 310 |
| 16 | 2008 | 215 | |
| 17 | 2008 | 49 | |
| 18 | 2006 | 388 | |
| 19 | 2006 | 119 | |
| 20 | 2005 | 242 |
About Rameen Beroukhim
Rameen Beroukhim is a scholar working on Genetics, Cancer Research, Molecular Biology, Neurology and Genetics, having authored 155 papers that have together received 17.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (44 papers), Cancer Genomics and Diagnostics (42 papers), Meningioma and schwannoma management (20 papers), Genomic variations and chromosomal abnormalities (13 papers), Epigenetics and DNA Methylation (12 papers), Histone Deacetylase Inhibitors Research (11 papers), Pituitary Gland Disorders and Treatments (10 papers) and Molecular Biology Techniques and Applications (9 papers). The work is most often cited by research in Cancer Research (6.1k citations), Genetics (1.8k citations), Oncology (4.1k citations), Molecular Biology (10.0k citations) and Pulmonary and Respiratory Medicine (3.2k citations). Rameen Beroukhim has collaborated with scholars based in United States, Germany and Norway. Frequent co-authors include Matthew Meyerson, Gad Getz, Steven E. Schumacher, Craig H. Mermel, Barbara Hill, William R. Sellers, Todd R. Golub, Mark A. Rubin, Travis Zack and Scott L. Carter. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Cancer Research, Journal of Neuro-Oncology and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.